|
Healionics Corporation Ships First Commercial Product Featuring STAR Biomaterial |
|
|
|
Sunday, 21 June 2009 |
Healionics Corporation, a provider of tissue regeneration and device bio-integration solutions to healthcare manufacturers, today announced the sale and shipment of the first commercial product featuring Healionics' STAR biomaterial. The product, TR-ClarifEYE, an innovative veterinary glaucoma implant marketed by TR BioSurgical, LLC (TRBIO), is scheduled for limited market launch in April 2009.
“We are very excited to announce the first commercial shipment of STAR, which is a significant milestone for Healionics and represents the Company’s first revenue from product sales," said Michel Alvarez, Chief Operating Officer and Vice President, Corporate Development of Healionics. "
TR-ClarifEYE is a unique veterinary glaucoma implant intended for primary glaucoma. TR-ClarifEYE is made from the STAR Biomaterial and is surgically implanted under the sclera. It is an angiogenic implant that restores aqueous outflow, reduces fibrosis and improves tissue integration.
Healionics’ proprietary STAR – Sphere Templated Angiogenic Regeneration – is a biomaterial scaffold designed to enhance bio-integration and promote healing of implanted medical devices. In addition to the veterinary ophthalmic market, Healionics currently has numerous research agreements in place evaluating STAR biomaterial in multiple human market applications including aesthetics, obesity management, diabetes care, advanced wound care, chronic pain management, end stage renal disease, and long-term infusion care.
About TR BioSurgical, LLC
TR BioSurgical, LLC, founded in May 2007, is a veterinary biomedical development company located in Chandler, Arizona. The company was founded by a group of veterinarians, scientists and business professionals to commercialize the most promising biomaterial technologies for veterinary medicine. For more information about TR BioSurgical, please visit www.trbio.com.
About Healionics Corporation
Healionics is a privately held biomaterials company whose mission is to be the leading provider of tissue regeneration and device biointegration solutions to healthcare manufacturers. The Company’s flagship STAR - Sphere Templated Angiogenic Regeneration – biomaterial scaffold is a next generation biomaterial scaffold designed to enhance bio-integration and promote healing of implanted medical devices. Healionics
Corporation is headquartered in Redmond, Washington. For more information, please visit www.healionics.com.
|
